𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Acute graft-versus-host disease: Pathophysiology, clinical manifestations, and management

✍ Scribed by Daniel Couriel; Humberto Caldera; Richard Champlin; Krishna Komanduri

Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
187 KB
Volume
101
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pathophysiology of acute graft-versus-ho
Pathophysiology of acute graft-versus-host disease
✍ Pavan Reddy 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB

Graft-versus-host disease (GVHD) has been the primary limitation to the wider application of allogeneic bone marrow transplantation (BMT). The pathophysiology of acute GVHD is complex and can be conceptualized to be a three-step process based on murine studies. In step 1, the conditioning regimen le

Lymphocytic pneumonitis as the manifesta
Lymphocytic pneumonitis as the manifestation of acute graft-versus-host disease of the lung
✍ Javier Bolaños-Meade; Olga Ioffe; Jamie C. Hey; Georgia B. Vogelsang; Görgün Akp 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB 👁 1 views

## Abstract Acute graft‐versus‐host disease is a common complication after allogeneic stem cell transplantation. It normally affects the skin, liver, and gut. We report a 54‐year‐old male who developed shortness of breath, cough, and bilateral pulmonary infiltrates in which the work‐up failed to de

Crypt loss is a marker of clinical sever
Crypt loss is a marker of clinical severity of acute gastrointestinal graft-versus-host disease
✍ Joshua Melson; Shriram Jakate; Henry Fung; Sally Arai; Ali Keshavarzian 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 286 KB

## Abstract Background: Crypt loss is a histological finding in acute gastrointestinal Graft‐Versus‐Host Disease (GI‐GvHD) of undefined clinical significance. Methods: Colonic crypt loss was graded in twenty‐three patients treated for GI‐GvHD following stem cell transplantation and then correlated

Intra-arterial methylprednisolone for th
Intra-arterial methylprednisolone for the management of steroid-refractory acute gastrointestinal and hepatic graft versus host disease
✍ Laurie A. Milner; Michael W. Becker; Steven H. Bernstein; Lauren Bruckner; Jonat 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 681 KB

Staging System and chromosomal abnormalities determined by standard metaphase karyotype and/or fluorescence in situ hybridization (FISH). Treatment-induced adverse events were graded according to the National Cancer Institute common terminology criteria for adverse events (CTCAE) version 4.0. For r